Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
A prototype cell partly capable of replicating itself has been created using 36 existing bacterial genes, but it's not really ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results